- Home
- GCMG vs TMCI Comparison
GCMG vs TMCI Comparison
Compare GCMG & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCMG
- TMCI
- Stock Information
- Founded
- GCMG 1971
- TMCI 2014
- Country
- GCMG United States
- TMCI United States
- Employees
- GCMG N/A
- TMCI N/A
- Industry
- GCMG Finance/Investors Services
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GCMG Finance
- TMCI Health Care
- Exchange
- GCMG Nasdaq
- TMCI Nasdaq
- Market Cap
- GCMG 604.3M
- TMCI 559.8M
- IPO Year
- GCMG N/A
- TMCI 2021
- Fundamental
- Price
- GCMG $12.68
- TMCI $7.94
- Analyst Decision
- GCMG Hold
- TMCI Hold
- Analyst Count
- GCMG 5
- TMCI 8
- Target Price
- GCMG $14.10
- TMCI $9.00
- AVG Volume (30 Days)
- GCMG 466.2K
- TMCI 404.1K
- Earning Date
- GCMG 05-06-2025
- TMCI 05-06-2025
- Dividend Yield
- GCMG 3.48%
- TMCI N/A
- EPS Growth
- GCMG N/A
- TMCI N/A
- EPS
- GCMG 0.03
- TMCI N/A
- Revenue
- GCMG $511,735,000.00
- TMCI $209,357,000.00
- Revenue This Year
- GCMG $12.30
- TMCI $10.86
- Revenue Next Year
- GCMG $8.67
- TMCI $10.06
- P/E Ratio
- GCMG $128.44
- TMCI N/A
- Revenue Growth
- GCMG 15.28
- TMCI 11.89
- 52 Week Low
- GCMG $8.53
- TMCI $3.92
- 52 Week High
- GCMG $14.48
- TMCI $13.24
- Technical
- Relative Strength Index (RSI)
- GCMG 34.22
- TMCI 32.10
- Support Level
- GCMG $12.48
- TMCI $8.10
- Resistance Level
- GCMG $13.14
- TMCI $8.71
- Average True Range (ATR)
- GCMG 0.29
- TMCI 0.55
- MACD
- GCMG -0.17
- TMCI -0.18
- Stochastic Oscillator
- GCMG 11.02
- TMCI 6.70
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.